image
RenovoRx, Inc. RNXT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.4
0.719 %
$ 51.2 M
Market Cap
-3.41
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
565.37%
EBIT Estimate
60.34%
Net Income Estimate
31.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets RenovoRx, Inc.
image
RNXT has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RNXT

image
$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RNXT

image
$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RNXT

image
$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)20232023202420242025202520262026202720272028202820292029